Ann: Cellmid Placement to Strategic Investor, page-5

Given the selling depth that's at a greater than 50% discount.

Always be wary of news announced on Friday after market close.

If they had some partnership to announce in the near future they would have secured with a loan rather than dilution. It is small though, so it may be in the not too distant future.

Price line sales dropped about two months ago to an average of $500 per day from $1500. This just doesn't happen in such a big step so I suspect their stock movements are now reported differently. If we assume that then sales seem to be going quite well again.

I checked the transaction rate on Evolis products sales with Advangen and these are up 20% on last quarter. So my tip is for increased sales in the January 4C report. Maybe cashflow positive for the month with the $1M?

DYOR.